COVID-19 Impact on Mapfre SA

COVID-19 Impact on Mapfre SA



COVID-19 Impact on Mapfre SA report provides a snapshot of the impact on the Mapfre SA in light of the COVID-19 outbreak.

This report provides in-depth company analysis, information and insights of COVID-19 impact on Mapfre SA.

It provides the impact of revised GDP growth estimates on growth prospects of Mapfre SA, exposure of the product portfolio and exposure by country/region due to virus outbreak.

The report brings together research, modeling and analysis expertise, giving access to information on the projected impacts of the outbreak on the insurer.

Key Highlights

- Exposure of the insurer to regions and countries impacted by COVID-19
- Key lines of businesses across regions where the insurers books are potentially impacted
- Share of key lines of businesses by country/region in context of COVID-19 impact

Scope

This report provides a comprehensive analysis of the impact of COVID-19 on Mapfre SA -
- It provides insights on Mapfre SAs exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the key business lines of the insurer that could be impacted due to the COVID-19 outbreak.

Reasons to Buy

- Take a strategic view of the business exposure of leading global insurers in COVID-19 outbreak.
- Understand the key factors shaping the growth and profitability outlook of the insurer.

1. Key findings as of July 21, 2020
COVID-19 Impact Analysis on Mapfre SA - Key findings
Geographic spread analysis - COVID-19 vs Mapfres lines of business
2. Regional Impact
The impact of COVID-19 on regional GDP levels
Allianzs Exposure: Life, Non-Life and PA&H Insurance Premium by Region vs Regional Impact Levels
Non-Life Exposure: Premium by Region and Segment vs Regional Impact Levels
Life Insurance Exposure: Premium by Region and Segment vs Regional Impact Levels
PA&H Exposure: Premium by Region and Segment vs Regional Impact Levels
3. Company Reaction
Indications from recruitment trends
Indications from stock pricing and sentiment scores
4. COVID-19 Impact Scores: Mapfre and other companies
5. Appendix
6. About GlobalData

Global Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery

USD 2400 View Report

COVID-19 Impact on Anheuser-Busch InBev, Update 2021

COVID-19 Impact on Anheuser-Busch InBev, Update 2021 COVID-19 Impact on Anheuser-Busch InBev, Update 2021 reports key findings as of 23rd March, 2021 based on market analysis and brand diversification by industry

USD 1450 View Report

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 Update

Coronavirus Disease 2019 (COVID-19) Impact on Clinical Trials, 2021 UpdateThis 62-page PowerPoint based report gives an important update to the previous year with an expert analysis on how COVID-19 is

USD 1495 View Report

Global Peptide Therapeutics Market (2021 Edition) – Analysis By Drug Type (Generic, Innovative), Manufacturing Type (In-House, Outsourced), Application,, By Region, By Country: Market Insights, Covid-19 Impact, Competition and Forecast (2021-2026)

Executive The Global Peptide Therapeutics Market is valued at USD 32.1 Billion in the year 2020. The growth of Peptide Therapeutics is directly associated with drug development. New drug discovery

USD 2400 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available